AMA: Trump administration requiring pricing information in TV drug ads

| 2 Min Read

Statement attributable to:

Barbara L. McAneny, MD 

President, American Medical Association

“The Trump Administration has taken a step in the right direction by requiring pricing information in direct-to-consumer television advertising of prescription drugs. Last year, the AMA called for regulations requiring the ads to include the manufacturer’s list price of those drugs, and we have supported similar legislative efforts. This small dose of transparency will help patients have a more complete picture when faced with prescription drug ads. 

 

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Patient in hospital bed

Nurse practitioners’ care linked to 11% longer stays in the ED

| 4 Min Read
Two healthcare workers in conversation

Mid-career physicians report higher burnout rates

| 6 Min Read
Patient in a wheelchair

Shape your state’s hardship exemptions to Medicaid work requirements

| 7 Min Read
Doctor with reassuring hand on smiling patient

What doctors want patients to know about lupus

| 13 Min Read